Latest filing published 26 May 2026 for Norwegian Cruise Line Holdings Ltd., €2.2M. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
This profile gathers the share dealings of John Chidsey across 4 companies, led by Encompass Health Corp, Norwegian Cruise Line Holdings Ltd. and HCA Healthcare, Inc. Over a trading history stretching from 4 January 2016 to 22 May 2026, the count stands at 78 filings.
On the market, this insider has only ever bought: 3 purchases, €2.2M in total. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Outside the open market, there are 75 share grants. 2026 to date brings 1 purchase and no sales.
Half of the purchases are above €26k and half below. Clusters matter here: 1 out of 3 purchases overlapped with buying by a colleague within 30 days. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time.
On 26 May 2026 came the latest disclosure, an open-market purchase for €2.2M in Norwegian Cruise Line Holdings Ltd. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 29 declarations